from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1143/mcr

LFCtreatmentdescriptionclass of inhibitor

0.567

Amikacinug/mL Amikacintranslation

1.733

Cap5-10ug/mL Capreomycintranslation

2.397

Rox10-50 ug/mL Roxithromycintranslation

0.562

SM2-5 ug/mL Streptomycintranslation

1.831

Tet5-10 ug/mL Tetracyclinetranslation

-1.240

Rif0.2-5ug/mL Rifampicintranscription

0.134

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.052

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.223

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.355

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.574

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.005

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.767

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.035

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.095

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.475

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.291

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.190

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.486

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.237

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.014

KCN5-20 ug/mL Potassium cyaniderespiration

-0.707

NaN30.2-2 mM Sodium aziderespiration

-1.363

Nigericin50 uM Nigericinrespiration

-0.545

TRC10-150 ug/mL Triclosanrespiration

0.487

TRZ10-25 ug/mL Thioridazinerespiration

0.869

Valinomycin0.5-10 uM Valinomycinrespiration

0.553

ZnSO42 mM ZnSO4respiration

0.232

menadione6-10 ug/mL Menadionerespiration

0.237

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.280

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.213

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.345

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.555

NRP_1Non-replicating persistence stage 1dosRassociated

0.060

Amp0.2mg/mL AmpicillincellWall

0.248

Cephalexin20-100 ug/mL CephalexincellWall

0.782

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.184

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.372

EMB10-20 ug/mL EthambutolcellWall

0.054

Eta12-40 ug/mL EthionamidecellWall

0.653

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.025

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.238

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.119

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.268

BZA0.12 mg/mL BenzamidearomaticAmides

-0.279

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.057

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.140

H2O24 mM hydrogen peroxideDNAdamaging

0.197

Levo10 ug/mL LevofloxacinDNAdamaging

-0.161

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.904

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.188

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.183

UVUV-irradiationDNAdamaging

0.480

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.409

Antimycin12.5-50 ug/mL Antimycin A?

0.378

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.065

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.067

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.723

PA8240.2-2 ug/mL PA-824?

0.463

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.188

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.234

Verapamil50 uM Verapamil?

0.286

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.489

methoxatin10-20 ug/mL Methoxatin?